Dermatomyositis as an early manifestation and a signifcant clinical precursor of lung cancer: Report of a rare case and review of the current literature

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 2, 2013, Pages 105-109

  Nikolaos, Tsoukalas ^a   Maria, Tolia ^a   Ioannis, Kostakis D ^a   Georgios, Lypas ^a   Nikolaos, Pistamaltzian ^a   Stamatina, Demiri ^a   Christos, Panopoulos ^a   Georgios, Koumakis ^a   Vasileios, Barbounis ^a   Anna, Efremidis ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Dermatomyositis; Early manifestation; Lung cancer; Precursor

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; CISPLATIN; CORTICOSTEROID; CREATINE KINASE; ETOPOSIDE; FRUCTOSE BISPHOSPHATE ALDOLASE; JO 1 ANTIBODY; PREDNISOLONE; TOPOTECAN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; COUGHING; DERMATOMYOSITIS; DYSPHAGIA; EYELID EDEMA; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER METASTASIS; LUNG SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE BIOPSY; MUSCLE WEAKNESS; NAIL DISEASE; PHYSICAL EXAMINATION; PRURITUS; RASH; SHOULDER PAIN; SURVIVAL TIME;

EID: 84873186647     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bohan A, Peter JB. Polymyositis and dermato-myositis (frst of two parts). N Engl J Med 1975; 292: 344-7.
2. Bohan A, Peter JB. Polymyositis and dermato-myositis (second of two parts). N Engl J Med 1975; 292: 403-7.
3. Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976 Jan; 84: 68-76.
4. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyo-sitis or polymyositis. A population-based study. N Engl J Med 1992; 326: 363-7.
5. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven infammatory myopathy. A population-based cohort study. Ann Intern Med 2001; 134: 1087-95.
6. Callen JP. The value of malignancy evaluation in patients with dermatomyositis. J Am Acad Dermatol 1982; 6: 253-9.
7. Cox NH, Lawrence CM, Langtry JA, Ive FA. Der-matomyositis. Disease associations and an evaluation of screening investigations for malignancy. Arch Dermatol 1990; 126: 61-5.
8. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001; 85: 41-5.
9. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT. Frequency of specifc cancer types in dermato-myositis and polymyositis: a population-based study. Lancet 2001; 357: 96-100.
10. Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore 2000; 29: 219-23.
11. Fujita J, Tokuda M, Bandoh S, Yang Y, Fukuna-ga Y, Hojo S, Ueda Y, Dobashi N, Dohmoto K, Ishida T, Takahara J. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int 2001; 20: 81-4.
12. Whitmore SE, Rosenshein NB, Provost TT. Ovarian cancer in patients with dermatomyosi-tis. Medicine (Baltimore) 1994; 73: 153-60.
13. Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, Loustaud-Ratti V, Bouyssou-Gauthier ML, Boulinguez S, Bédane C, Jauberteau MO, Vidal E, Bonnetblanc JM. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol 2002; 138: 885-90.